Clinical Trial Update: A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 1/2 study evaluating the safety and tolerability of Vonsetamig in adults with chronic kidney disease who require ki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Vonsetamig (vonsetamig)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Chronic Kidney Disease (CKD) | Phase 1, Phase 2 | Status: RECRUITING